Variant report
Variant | nsv520330 |
---|---|
Chromosome Location | chr6:120432127-120484600 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186701632 | chr6:120437624-120437625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140556615 | chr6:120437691-120437692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556437177 | chr6:120437713-120437714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150473907 | chr6:120437723-120437724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138339918 | chr6:120437750-120437751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149225939 | chr6:120437778-120437779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144971174 | chr6:120437834-120437835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75849510 | chr6:120437836-120437837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138833920 | chr6:120437842-120437843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577501422 | chr6:120437872-120437873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369059440 | chr6:120437881-120437882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530168292 | chr6:120437888-120437889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550307514 | chr6:120437921-120437922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142035290 | chr6:120437970-120437971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531531343 | chr6:120437985-120437986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376256936 | chr6:120438038-120438039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551314911 | chr6:120438160-120438161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192768867 | chr6:120438187-120438188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535273934 | chr6:120439203-120439204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370260820 | chr6:120439240-120439241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184307968 | chr6:120439250-120439251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575239649 | chr6:120439280-120439281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543784703 | chr6:120439327-120439328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557094096 | chr6:120439340-120439341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577242218 | chr6:120439356-120439357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545986524 | chr6:120439416-120439417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189519355 | chr6:120439543-120439544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527476269 | chr6:120439560-120439561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540852562 | chr6:120439579-120439580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572129997 | chr6:120439580-120439581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554669568 | chr6:120445228-120445229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181086222 | chr6:120445262-120445263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560730195 | chr6:120445263-120445264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9482007 | chr6:120445265-120445266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs55799404 | chr6:120445314-120445315 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs531381437 | chr6:120445349-120445350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs377225430 | chr6:120445360-120445361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185874366 | chr6:120445366-120445367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527588493 | chr6:120445414-120445415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546939546 | chr6:120445460-120445461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560740379 | chr6:120445510-120445511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529729889 | chr6:120445528-120445529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531300782 | chr6:120445612-120445613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34183541 | chr6:120445633-120445634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200896422 | chr6:120445679-120445680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138399836 | chr6:120445680-120445681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549592205 | chr6:120445715-120445716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4623278 | chr6:120445719-120445720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149141511 | chr6:120445733-120445734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539227840 | chr6:120445781-120445782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 18698023 | CNVD |
Mental retardation | 18854857 | CNVD |
Leukemia | 18688285 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21611746 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:120437600-120437800 | Enhancers | Primary B cells from cord blood | blood |
2 | chr6:120437600-120438200 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr6:120437600-120438200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr6:120439200-120439600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr6:120445200-120445600 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr6:120445600-120448600 | Weak transcription | Primary B cells from peripheral blood | blood |
7 | chr6:120448600-120449400 | ZNF genes & repeats | Primary B cells from peripheral blood | blood |
8 | chr6:120449400-120449600 | Weak transcription | Primary B cells from peripheral blood | blood |
9 | chr6:120449600-120450200 | Enhancers | Primary B cells from cord blood | blood |
10 | chr6:120449600-120450400 | Enhancers | Primary B cells from peripheral blood | blood |
11 | chr6:120450200-120450400 | Flanking Active TSS | Primary B cells from cord blood | blood |
12 | chr6:120450400-120451200 | Enhancers | Primary B cells from cord blood | blood |
13 | chr6:120450400-120451400 | Weak transcription | Primary B cells from peripheral blood | blood |
14 | chr6:120451400-120452200 | Enhancers | Primary B cells from peripheral blood | blood |
15 | chr6:120468200-120468600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr6:120468400-120468800 | Enhancers | Placenta | Placenta |
17 | chr6:120468600-120468800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr6:120470200-120471200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr6:120471200-120475200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr6:120475200-120475600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr6:120475600-120476000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |